Skip to Content

PARP inhibitors are showing promising results in treating ovarian cancer 

During the ESMO22 congress, BestPractice Nordic will meet one of the leading specialists in the treatment of Ovarian Cancer, Mansoor Raza Mirza. He will give his perspective on PARP inhibitors’ role in managing ovarian cancer.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top